Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LIRAGLUTIDE 3-PAK 18 MG/3 ML

liraglutide
$35.3919per ML

Strength

6 mg/mL

Manufacturer

Hikma Pharmaceuticals USA Inc.

NDC

00143914403

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

LIRAGLUTIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215503

On Market Since

12/24/2024

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

-10.2%

3M

-26.4%

6M

-33.6%

1Y

-44.8%

3Y

N/A

5Y

N/A

All

-51.1%

Generic Alternatives

4 alternatives • Same active ingredient

LIRAGLUTIDE 3-PAK 18 MG/3 ML
Generic
71288056384•Meitheal Pharmaceuticals Inc.
$35.3919
LIRAGLUTIDE 3-PAK 18 MG/3 ML
Generic
00480366722•Teva Pharmaceuticals USA Inc.
$35.3919
LIRAGLUTIDE 2-PAK 18 MG/3 ML
Generic
00143914402•Hikma Pharmaceuticals USA Inc.
$38.7526
+9% more
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
+146% more

Related Drugs

Same classification

LIRAGLUTIDE 3-PAK 18 MG/3 ML
Generic
70748034603•Lupin Pharmaceuticals Inc.
$35.3919
per ML
LIRAGLUTIDE 2-PAK 18 MG/3 ML
Generic
70748034602•Lupin Pharmaceuticals Inc.
$38.7526
per ML
LIRAGLUTIDE 5-PAK 18 MG/3 ML
Generic
00480725046•Teva Pharmaceuticals USA Inc.
$70.3162
per ML
EXENATIDE 10 MCG DOSE PEN INJ
Generic
70121168601•Amneal Pharmaceuticals LLC
$299.5033
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy